Legal Representation
Attorney
Todd Braverman, Esq.
USPTO Deadlines
Next Deadline
140 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
December 04, 2025
Extension Available
Until June 04, 2025
Application History
32 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jun 2, 2025 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Jun 2, 2025 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Jun 2, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Dec 30, 2024 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Dec 30, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Dec 9, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Nov 11, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Nov 11, 2024 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Jun 4, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Apr 2, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Apr 2, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 13, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 28, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 28, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Feb 28, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 28, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 11, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
Oct 6, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Oct 2, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Oct 2, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Oct 2, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 25, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Sep 25, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 25, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 3, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Aug 3, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Aug 3, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Aug 3, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 8, 2022 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
Nov 8, 2022 | TAEA | I | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | Loading... |
Oct 25, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 24, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and needles all pre-filled with vaccines and biological preparations for the treatment of a wide variety of diseases, conditions, and disorders, specifically, allergies, bacterial infections, diabetes, infertility, migraine headaches, arthritis, rheumatoid arthritis, lupus, low testosterone, obesity, and chronic pain; pharmaceutical preparations for the prevention and treatment of a wide variety of diseases, conditions, and disorders, specifically, allergies, bacterial infections, diabetes, infertility, migraine headaches, arthritis, rheumatoid arthritis, lupus, low testosterone, obesity, chronic pain, and antibiotics and anti-diabetic preparations and pharmaceuticals
Additional Information
Translation
The wording "PROVENSA" has no meaning in a foreign language.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"SHARPS" AND "ULTRA-LOW WASTE"